NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of AlloVir, Inc. (NASDAQ: ALVR) and Kalaris Therapeutics is fair to AlloVir shareholders.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AlloVir, Inc. ...
AlloVir (NASDAQ:ALVR) just reported results for the fourth quarter of 2023. AlloVir reported earnings per share of -53 cents. This was below the analyst estimate for EPS of -43 cents. The company did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback